Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-09-001916
Filing Date
2009-02-27
Accepted
2009-02-27 06:02:22
Documents
9
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2190913z10-k.htm 10-K 869414
2 EX-10.24 a2190913zex-10_24.htm EX-10.24 73929
3 EX-10.25 a2190913zex-10_25.htm EX-10.25 179366
4 EX-10.26 a2190913zex-10_26.htm EX-10.26 63898
5 EX-23.1 a2190913zex-23_1.htm EX-23.1 4018
6 EX-31.1 a2190913zex-31_1.htm EX-31.1 7252
7 EX-31.2 a2190913zex-31_2.htm EX-31.2 7256
8 EX-32.1 a2190913zex-32_1.htm EX-32.1 4587
9 G35646.JPG g35646.jpg GRAPHIC 61331
  Complete submission text file 0001047469-09-001916.txt   1295742
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29889 | Film No.: 09639579
SIC: 2834 Pharmaceutical Preparations